News | Coronavirus (COVID-19) | July 30, 2020

Radiology Publishes WHO Rapid Advice Guide on Chest Imaging for COVID-19

A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

July 30, 2020 — A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

The rapid guide includes three diagnosis recommendations and four management recommendations covering patients with suspected or confirmed COVID-19 with different levels of disease severity, throughout the care pathway from outpatient facility or hospital entry to home discharge. It also offers considerations about implementation, monitoring and evaluation and identifies research needs.

This guide is primarily intended for health professionals involved in the diagnosis of COVID-19 and in the management of COVID-19 patients, but can also benefit hospital managers and planners, policymakers, hospital architects, biomedical engineers, medical physicists, logistics staff, and control officers involved in water/sanitation and infection prevention.

The purpose of the guide is to support WHO Member States in their response to the COVID-19 pandemic by providing up-to-date guidance on use of chest imaging in adult patients with suspected or confirmed COVID-19, including chest radiography, computed tomography and lung ultrasound. It covers the care pathway from outpatient facility or hospital entry to home discharge. The guidance is provided for patients with different levels of disease severity, from asymptomatic individuals to critically ill patients.

For more information: www.pubs.rsna.org

Related Content

The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021
September 23, 2021 — GE has entered into an
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy.

Semi-automatic lesion identification: (A) Manual ROI indication. In blue, it is possible to observe the axes that cross the lesion manually delineated by the radiologist on a plane of the MPR. The intensity of the lesion boundary (estimated) is represented with a red outline. (B) Additional axes can be dragged onto other orthogonal MPR views. From left to right, it is possible to observe the initial long axis outlined by the radiologist and the 2D contours on the axial, coronal and sagittal views of the lesion used as a starting point for the RPM algorithms. (C) Resulting 3D contour of the lesion (in blue).

News | Radiomics | September 21, 2021
September 21, 2021 —  HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed ...
News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc